Your guide to TruCheck test results
TruCheck is a pioneering multi-cancer early detection test—a test that identifies signals associated with a broad range of cancer types using a single blood sample. In clinical studies, TruCheck was able to detect signals shared by over 70 types of cancer.
There are three possible results:
– Positive for malignancy: Circulating Tumour Cells (CTCs) were detected in the blood sample. The analysis suggests the likely organ of origin and malignancy type.
– Negative for malignancy: CTCs are not detected in the given sample. The chance of
having an active malignancy present in the body is low.
– Indeterminate: CTCs were detected in the given blood sample; however, type of malignancy or organ of origin could not be determined. A recollection of a blood sample is required to determine result (free of charge).
A ‘Negative for malignancy’ result from the TruCheck test means that, within the accuracy limits of the test, no Circulating Tumor Cells (CTCs) were detected in your blood sample.
This suggests that, at the time of testing, there is likely no active cancer in your body that the test is designed to detect. However, it’s important to note that there are some cancers that TruCheck does not cover. Therefore, a ‘negative’ result doesn’t rule out the presence of those specific cancers.
Continuing with your regular health check-ups and any additional cancer screenings recommended by your healthcare provider remains crucial.
A ‘Positive for malignancy’ result from the TruCheck test means that Circulating Tumor Cells (CTCs), which are often an indication of cancer, were detected in your blood sample. Along with this result, the test also provides an analysis suggesting the likely organ of origin and the type of malignancy. This means that the test tries to predict with high accuracy the specific organ that could be affected by cancer.
However, this is a screening test and not a definitive diagnosis. If you receive a ‘positive’ result, your TruCheck report should be reviewed by your healthcare provider, who can guide you on the next steps, which may include further diagnostic testing.
It’s important to remember that only a healthcare professional can confirm a cancer diagnosis.
TruCheck is an advanced non-invasive blood test which provides evidence of an underlying malignancy via a safe, simple and quick blood draw. TruCheck evaluates blood samples to detect ‘Circulating Tumour Cells’ (CTCs), which are cancer cells that escape from the tumour and enter the blood stream. TruCheck enriches these CTCs from the blood sample and confirms their identity via a process called ‘Immunocytochemistry’ (ICC). A positive CTC finding is indicative of the presence of an underlying cancer whereas when CTCs are undetectable, the patient may not have a cancer.
Trucheck Intelli can find over 70 types of solid organ cancers.
It detects common cancers such as Breast, Lung, Bowel, Prostate, and many other cancers which are not routinely screened for.
These cancers account for 81% of all cancer cases globally and include several types of aggressive cancer.
When cancer is present in someone, it sheds tiny cells and tumour fragments into the bloodstream, called circulating tumour cells (CTCs).
These cells are the main reason cancer eventually spreads in the body, especially if they move in clusters (a group).
Trucheck can detect them from your blood sample and indicate the likely organ of origin.
Healthcare professionals can then carry out targeted follow up investigations and treat patients if necessary.
Many cancers are without a current screening process for early detection. Some cancers cause no symptoms until they have spread throughout the body.
Trucheck intelli is a simple revolutionary blood test which can help you find cancer early, before you show symptoms.
It also looks for multiple cancers, many of which are not covered in routine screening.
The test can help avoid late cancer detection which can lead to intensive and expensive treatments.
1 in 2 people in the UK, born after 1960, will be diagnosed with cancer in their lifetime.
Currently, almost half of those people are diagnosed after the cancer has spread.
Finding cancer early, before you have symptoms, can significantly improve your chances of survival.
You can request the TruCheck test by clicking ‘Get started’ at the top of this page. You will be asked to fill in your details, which includes some clinical questions to determine your eligibility. Your request will then be reviewed to determine your eligibility. If the TruCheck test is suitable for you, we will then arrange to visit you to take a blood draw by one of our trained professionals. We will then take your blood sample to the laboratory where it will be analysed. Results are usually available two weeks later.
No. It is only suitable for people who have not had cancer.
You should discuss this with your Doctor. It can be part of your yearly check-up.
No. It is designed to be used in addition to, and not replace, conventional screening.
Trucheck Intelli will detect the cancers it screens for 95% of the time.
There is a possibility that in around 1% of cases the test may show positive, but cancer is not actually present.
The TruCheck Intelli test, which is the most comprehensive test available, is £1190.
As part of the test price, your request will be reviewed to determine eligibility for the test (you will receive a full refund if you are not eligible). We will arrange a trained professional to visit you to take a blood sample. We will then transport your blood sample to the laboratory on the same day using cold storage to ensure your sample reaches the lab in optimal condition. The laboratory will then analyse your sample. Results will then be provided to you within two weeks. If you receive a positive result, we will arrange a follow up consultation to explain your next steps. This is all included in the test price. There are no hidden costs.
You can get a full refund within 30 days as long as the lab has not started analysing your sample. Please see our refund policy for more details.
If it’s determined that the test is not suitable for you (eg. you are already receiving treatment for cancer) then you will receive a full refund within 10 working days.
Click ‘Get Started’ at the top of this page. You will be guided through our booking portal which contains a number of questions which help to determine if the test is suitable for you. It will take approximately 10 minutes and should be completed in one sitting.
We will determine if you’re eligible for the test, this usually takes a maximum of 3 working days. If you are eligible then we will contact you to arrange a convenient time to visit you to take a blood sample, or you can arrange your own blood draw if preferred. If you are not eligible then you will receive a full refund.
A trained professional will take a small blood sample from your arm. The appointment shouldn’t take more than 10 minutes.
The person performing your blood draw will take your sample and pass it to our medical courier where it is then transported the same day to the laboratory. By transporting it the same day, we ensure the most accurate results as long delays between a blood draw and delivery can cause blood samples to deteriorate.
You will typically receive your results within two weeks from your blood draw.
A positive result means the test has detected an indication of cancer. Your Doctor should discuss with you suitable next steps to confirm if cancer is present.
A negative result means the test detected no evidence of cancer when you took the test.
If you receive a positive result, we will arrange a free consultation with one of our doctors who will explain what the results mean for you and what your next steps should be.
The TruCheck test is suggested for use in adults with a higher risk of cancer, typically those aged 50 or above. TruCheck does not detect all types of cancers and should be considered a supplemental tool alongside routine cancer screening tests advised by your healthcare provider. The primary goal of TruCheck is to identify cancer signals and predict their origin within the body. It is not recommended for use in individuals who are pregnant, under the age of 40, or currently undergoing active cancer treatment.
Results must be analysed by a healthcare professional, taking into account the patient’s medical history, clinical signs, and symptoms. A result of “No Cancer Signal Detected” does not definitively exclude the presence of cancer. Likewise, a “Cancer Signal Detected” result necessitates further diagnostic evaluation through established medical procedures (such as imaging) to confirm the presence of cancer.
In cases where further testing does not confirm cancer, this could indicate either the absence of cancer or that the test was unable to detect it, including situations where the cancer is located in a different part of the body. Be aware that false-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) results can occur.
1. Akolkar et al. B15: Circulating tumor cells express tissue specific antigens in multiple cancers. Clin Cancer Res.2020;
26(11_Suppl). DOI: 10.1158/1557-3265.LiqBiop20-B15.
2. Akolkar et al. Circulating ensembles of tumor-associated cells: A redoubtable new systemic hallmark of cancer. Int. J.
Cancer:2019; 146, 3485-3494. DOI: 10.1002/ijc.32815.
3. Gaya A et al. Evaluation of circulating tumor cell clusters for pan-cancer noninvasive diagnostic triaging. Cancer Cytopathol.
2020; 129 (3) 226-238 doi: 10.1002/cncy.22366.
4. Ranade A et al. Hallmark Circulating Tumor-Associated Cell Clusters Signify 230 Times Higher One-Year Cancer Risk. Cancer
Prev Res. 2021;14:11-6 DOI:10.1158/1940-6207.CAPR-20-0322.
5. Crook T et al. Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells. Cancers
(Basel). 2022 Jul; 14(14): 3341. DOI: 10.3390/cancers14143341.
